TG Therapeutics, Inc. TGTX
$56.19
-2.16%
at last close
Financials (TTM)
- Revenue
- $799.54 million
- Net Income
- $441.49 million
- Net Margin
- 55.22%
- Return on Equity
- 73.08%
- Debt-to-Equity
- —
- P/E Ratio
- 20.43
- Price / Book
- 14.55
- Price / Sales
- 10.99
Over the trailing twelve months, TG Therapeutics, Inc. generated revenue of $799.54 million and net income of $441.49 million, a net margin of 55.22%.
At the last closing price of $56.19, TGTX trades at 20.43 times trailing earnings and 10.99 times sales, with a market capitalization of $8.79 billion.
Key Stats
- Last Close
- $56.19
- Market Cap
- $8.79 billion
- 52-Week Range
- $26.76 – $59.30
- Average Volume
- 1.90 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.